Krishna Institute of Medical Sciences Ltd.

NSE: KIMS | BSE: 543308

Expensive Rocket

Download real time

736.80 -9.35 (-1.25%)

55.43% Gain from 52W Low

201.5K NSE+BSE Volume

NSE 22 Aug, 2025 3:31 PM (IST)

29,482.2

Market Cap

High in industry

0.8

Beta 1Year

Very Low volatility

Krishna Institute of Medical Sciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for KIMS, BSE:543308 Krishna Institute of Medical Sciences Ltd.

Search Inside the pdf :

Krishna Institute of Medical Sciences Ltd.

08 Aug 2025

736.80

-1.25%

Krishna Institute of Medical Sciences (KIMS IN) Q1FY26 Result...

Buy: Krishna Institute of Medic...

Target

Prabhudas Lilladhar

Krishna Institute of Medical Sciences (KIMS) reported EBITDA growth of 7.4% YoY, below our estimates impacted by higher losses from new units. Our FY26E EBITDA stands reduced by 5%, however FY27E EBITDA broadly remains unchanged as new units are likely to ramp up. The company is on track to commercialize greenfield expansions at Bengaluru markets by Q2FY26. New leadership team hiring across Karnataka and Kerala provides comfort for faster ramp-up in these clusters. Given its lean cost structure and partnership...

Promoters released all pledges in Jun 2025 qtr.

Krishna Institute of Medical Sciences Ltd.

08 Aug 2025

736.80

-1.25%

Result Update:Krishna Institu.

Buy: Krishna Institute of Medic...

Target

Axis Direct

We maintain our BUY rating on the stock with a target price of Rs 830/share,

Prabhudas Lilladhar increased Buy price target of Krishna Institute of Medical Sciences Ltd. to 815.0 on 08 Aug, 2025.

Krishna Institute of Medical Sciences Ltd.

30 Jun 2025

736.80

-1.25%

Krishna Institute of Medical Sciences (KIMS IN) Management Meet...

Buy: Krishna Institute of Medic...

Prabhudas Lilladhar

Given its lean cost structure and partnership with local doctors/ leadership outside Andhra Pradesh (AP) and Telangana, the management remains confident of achieving faster breakeven and +25% OPM across Maharashtra,...

Promoters released all pledges in Jun 2025 qtr.

Krishna Institute of Medical Sciences Ltd.

25 Jun 2025

736.80

-1.25%

KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED

Accumulate: Krishna Institute of Medic...

Recommendation Target

Geojit BNP Paribas

KIMS demonstrated strong financial performance, with key parameters such as average revenue per occupied bed (ARPOB) and average revenue per patient (ARPP) growing on a YoY basis. A spate of initiatives, expansions and new equipment were launched during the year. The company is confident about its future prospects and expects to benefit from its commitment to quality services and expertise. With new units poised to contribute to the company's performance, KIMS...

Krishna Institute of Medical Sciences Ltd. has gained 51.33% in the last 1 Year

Krishna Institute of Medical Sciences Ltd.

14 May 2025

736.80

-1.25%

Growth levers across clusters in place; valuation pricey

Hold: Krishna Institute of Medic...

ICICI Securities Limited

Krishna Institute of Medical Sciences’ (KIMS) delivered robust performance in Q4FY25 with revenue/EBITDA/PAT surging 26%/29%/49%, respectively. Existing clusters of AP/ Telangana grew 19%/23% while EBITDA growth was much faster at 37%/34% YoY, respectively.

Prabhudas Lilladhar increased Buy price target of Krishna Institute of Medical Sciences Ltd. to 815.0 on 08 Aug, 2025.

Krishna Institute of Medical Sciences Ltd.

14 May 2025

736.80

-1.25%

Krishna Institute of Medical Sciences (KIMS IN) Q4FY25 Result...

Buy: Krishna Institute of Medic...

Prabhudas Lilladhar

YoY, adj for one offs; was in line with our estimates. Our FY26E/FY27E EBITDA broadly remain unchanged. The company is on track to commercialize greenfield expansions across Thane and Bengaluru markets by H1FY26. New leadership team hiring across Karnataka and Kerala provides comfort for faster ramp-up in these clusters. Given its lean cost structure and partnership...

Promoters released all pledges in Jun 2025 qtr.

Krishna Institute of Medical Sciences Ltd.

11 Apr 2025

736.80

-1.25%

Real Wealth is Good Health

Buy: Krishna Institute of Medic...

FundsIndia

Commissioned 200-bed multispecialty hospital in Guntur (Q3FY25) under O&M model.

Krishna Institute of Medical Sciences Ltd. is trading above its 200 day SMA of 636.2

Krishna Institute of Medical Sciences Ltd.

27 Feb 2025

736.80

-1.25%

KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED

Buy: Krishna Institute of Medic...

Geojit BNP Paribas

Number of FII/FPI investors increased from 226 to 257 in Jun 2025 qtr.

Krishna Institute of Medical Sciences Ltd.

11 Feb 2025

736.80

-1.25%

Current valuations discount near-term earnings growth

Hold: Krishna Institute of Medic...

Recommendation Target

Khambatta Securities

? Krishna Institute of Medical Sciences (KIMS) reported a robust 29.7% y-o-y increase in total income to Rs 790.2 crore in 3Q FY25.
? Calculated blended occupancy rate (basis total bed capacity) was 50.7% in 3Q FY25, compared to 56.8% in 2Q FY25.